Stopping Weight Loss Injections: What Happens
What the Research Actually Shows About Regain, the Three Ways to Come Off Safely, and How to Decide Which One Fits You — A Physician’s Guide for Des Plaines, Park Ridge, Niles, and the Northwest Suburbs
By Dr. Naaz Aziz, MD, Board-Certified Family Medicine Physician · Zorah Med Spa, Des Plaines, IL · Updated September 2026
Zorah Med Spa — 1645 S River Road, Suite 14, Des Plaines, IL 60018, River Plaza Professional Building, off River Road near the Rosemont border, serving Des Plaines, Park Ridge, Niles, and surrounding suburbs. Six days a week, 9 to 5, Monday through Saturday. (708) 412-4040 · schedule a consultation online.
Quick answer: Stopping semaglutide, tirzepatide, or retatrutide without a plan leads most patients to regain a significant portion of the weight they lost within a year, because the medication was suppressing appetite signals that return once it’s out of your system. That’s not a reason to avoid these medications — it’s the same principle as blood pressure medication — but it is a reason to decide how you’ll come off before you start. There are three real paths: staying on a low maintenance dose indefinitely, tapering gradually while testing your habits, or transitioning off entirely with a structured maintenance plan. Which one fits you is a conversation with your physician, not something a subscription decides for you when a card declines.
Why Weight Comes Back When the Medication Stops
GLP-1 medications work by mimicking a hormone your gut naturally releases after eating — one that tells your pancreas to manage blood sugar, slows digestion so meals satisfy longer, and signals your brain that you’re full. For most people with obesity, that natural signal is weak or short-lived, which is why willpower alone rarely solves it. This is the same biology behind every medical weight loss program we run. The medication restores the signal artificially. Once it’s stopped, the signal fades along with it, and appetite tends to return to where it was before treatment — not because of any failure on your part, but because the underlying biology that made losing weight difficult in the first place hasn’t changed.
What the Research Actually Shows
In clinical trials, patients who stopped semaglutide after reaching their target weight regained roughly two-thirds of the weight they’d lost within about a year of stopping. This isn’t a reason to avoid starting — it’s a reason to plan the exit as seriously as the entry. Patients who build habits during treatment, particularly around protein intake and resistance exercise, and who have a structured plan for what happens after stopping, tend to hold onto more of their progress than those who simply stop and hope.
The Three Ways to Come Off, Honestly
Continuing at the lowest effective dose. For many patients, this is the most reliable way to maintain results long-term — similar to staying on a low dose of blood pressure medication rather than stopping once numbers normalize. This doesn’t mean staying at your highest treatment dose forever; it often means finding the minimum dose that keeps appetite regulated.
Tapering gradually. Reducing the dose step by step over months while testing whether your habits — meal structure, protein intake, activity level — hold up without the medication’s full effect. This approach works best for patients who’ve built strong habits during treatment and want to see how much of the result they can maintain independently.
Transitioning off with a structured maintenance plan. Stopping the medication entirely, but replacing its effect with a deliberate plan: consistent protein targets, regular resistance training, and scheduled follow-up weigh-ins rather than hoping momentum carries forward on its own. This is the highest-effort path, and it works best for patients who are prepared to treat maintenance as seriously as they treated the initial loss.
None of these is universally “better” — the right choice depends on your history, how your body responded to treatment, and how sustainable each option is for your actual life. At Zorah, this decision is made together with Dr. Naaz Aziz, not handed to you as a default renewal.
What Protects Your Results, Regardless of Which Path You Choose
Two things matter more than almost anything else in the maintenance conversation: protein intake and resistance exercise. Some of the weight lost on any GLP-1 medication is lean muscle, not just fat. Hitting a consistent daily protein target and keeping resistance training in your week — two to three times, not necessarily daily — helps ensure that what you’ve lost is weighted toward fat rather than muscle, and that your metabolism doesn’t drop further than it needs to. This matters whether you’re staying on a low dose, tapering, or transitioning off completely. Many patients also find that skin tightening becomes a bigger concern after significant weight loss than they expected going in — something worth discussing alongside your maintenance plan, whether that’s through exosome therapy or other facial treatments as your body composition changes.
How This Fits Into a Membership Plan
If you’re on one of our weight loss memberships — Body Refinery, Elite Fat Burn, or Stubborn Fat Melt — the exit plan should be part of the conversation from the start, not an afterthought once you’ve hit your goal weight. A responsible membership doesn’t quietly auto-renew you at the same dose indefinitely without checking whether that’s still the right plan; it includes a checkpoint where you and your physician decide together whether to continue, taper, or transition off.
Why This Conversation Should Happen Before You Start, Not After
The biggest mistake we see isn’t choosing the wrong exit strategy — it’s not having one at all until the medication is already stopped, usually because of cost, a supply issue, or simply reaching a goal weight without a next step in mind. Ask your physician at your very first consultation: what does stopping look like, eventually, for someone like me? A good answer should be specific to your situation, not a generic script.
Frequently Asked Questions
Will I definitely regain weight if I stop?
Without a plan, most patients regain a significant portion of what they lost within about a year. With a plan — continuing at a low dose, tapering, or a structured maintenance approach — the outcome is much more in your control.
Is it bad to stay on a low dose indefinitely?
No. For many patients, this is the most effective long-term strategy, similar to how other chronic conditions are managed with ongoing low-dose medication rather than a one-time treatment.
Does tapering work better than stopping all at once?
Tapering tends to give a clearer picture of which habits are actually sustainable on their own, since you’re testing them gradually rather than removing the medication’s effect all at once.
What’s the single most important thing for maintaining results?
Protein intake and resistance exercise, consistently, regardless of which path you take off the medication.
Can I switch between semaglutide, tirzepatide, and retatrutide instead of stopping?
Sometimes, depending on your history and how you’ve responded — this is a conversation to have directly with your physician rather than assuming one is simply a stronger version of another.
Where are you, and how do I book a consultation?
1645 S River Road, Suite 14, Des Plaines, IL 60018, open 9 to 5, six days a week. Book onlineor call; new patients are welcome.
Plan the End at the Beginning
The medication works. What decides whether the results last is what happens after — and that’s worth a real conversation before you ever start. Schedule a weight loss consultation with Dr. Aziz online or call (708) 412-4040. Still have questions? Our Med Spa FAQ covers more, or you can reach out directly.
Zorah Med Spa · 1645 S River Road, Suite 14, Des Plaines, IL 60018 · (708) 412-4040 · Monday–Saturday, 9 AM–5 PM
GLP-1 medications carry risks and contraindications that vary by individual, and outcomes after stopping vary by patient. This guide is educational; your specific maintenance plan is decided by a licensed physician after a consultation and evaluation.
